ARTICLE
|
doi:10.20944/preprints202305.0173.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
biomarkers; immunotherapy markers; advanced serous ovarian carcinoma; immunohistochemistry; p53; MSI
Online: 4 May 2023 (03:39:48 CEST)